Efficacy and safety of everolimus in Chinese metastatic HR positive, HER2 negative breast cancer patients: a real-world retrospective study

BACKGROUND: Everolimus combined with endocrine therapy has been proved to be effective among postmenopausal women with hormone receptor-positive human epidermal growth factor receptor-2 negative (HR+/HER2-) metastatic breast cancer (MBC). We aimed to evaluate the efficacy and safety of everolimus pl...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Chengcheng, Zhao, Yannan, Wang, Biyun, Hu, Xichun, Wang, Zhonghua, Zhang, Jian, Zhang, Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601780/
https://www.ncbi.nlm.nih.gov/pubmed/28938684
http://dx.doi.org/10.18632/oncotarget.16336

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601780/
https://www.ncbi.nlm.nih.gov/pubmed/28938684
http://dx.doi.org/10.18632/oncotarget.16336

Ejemplares similares